Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.

Two clinical isolates of Klebsiella pneumoniae from seriously ill patients in Chicago, Ill., have been identified as resistant to ceftazidime and aztreonam but susceptible to other cephalosporins. This unusual antibiogram was shown to be due to a novel plasmid-mediated beta-lactamase which readily h...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Quinn, J P, Miyashiro, D, Sahm, D, Flamm, R, Bush, K
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1989
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172682/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2684007/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.9.1451
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!